U.S. markets open in 33 minutes

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
31.55+0.69 (+2.24%)
At close: 4:00PM EST

32.03 +0.48 (1.52%)
Pre-Market: 8:24AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close30.86
Open31.22
Bid30.71 x 1400
Ask32.71 x 800
Day's Range30.12 - 32.21
52 Week Range15.17 - 34.09
Volume4,363,980
Avg. Volume4,153,380
Market Cap14.889B
Beta (5Y Monthly)0.87
PE Ratio (TTM)N/A
EPS (TTM)-0.60
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
3% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ELANCO ANIMAL HEALTH INC (ELAN) Q4 2020 Earnings Call Transcript
    Motley Fool

    ELANCO ANIMAL HEALTH INC (ELAN) Q4 2020 Earnings Call Transcript

    ELAN earnings call for the period ending December 31, 2020.

  • Benzinga

    Recap: Elanco Animal Health Q4 Earnings

    Shares of Elanco Animal Health (NYSE:ELAN) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 47.83% over the past year to $0.12, which beat the estimate of $0.09. Revenue of $1,139,700,000 higher by 44.82% year over year, which beat the estimate of $1,060,000,000. Outlook Elanco Animal Health sees Q1 adjusted EPS of $0.20-$0.25. Details Of The Call Date: Feb 24, 2021 View more earnings on ELAN Time: 08:00 AM ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.elanco.com%2F&eventid=2947454&sessionid=1&key=5FB43C4D26A85C954E0546804562785D®Tag=&V2=false&sourcepage=register Technicals 52-week high: $34.09 Company's 52-week low was at $15.17 Price action over last quarter: Up 3.03% Company Overview Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production. See more from BenzingaClick here for options trades from BenzingaRecap: Lowe's Companies Q4 EarningsRecap: Royal Bank of Canada Q1 Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results
    Business Wire

    Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results

    Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year of 2020, increased guidance for full year 2021, and provided initial guidance for the first quarter of 2021. The results reflect the inclusion of the Bayer Animal Health business that Elanco acquired on August 1, 2020.